Fed Regist. 1999 Mar 8;64(44):10947-9.
The Food and Drug Administration (FDA) is classifying the nasal dilator, intranasal splint, and the bone particle collector into class I (general controls). FDA is also exempting the devices from the requirements of premarket notification. This action is taken under the Federal Food, Drug, and Cosmetic Act (the act), as amended by the Medical Device Amendments of 1976 (the amendments), the Safe Medical Devices Act of 1990 (SMDA), and the Food and Drug Administration Modernization Act of 1997 (FDAMA).
美国食品药品监督管理局(FDA)正在将鼻扩张器、鼻内夹板和骨颗粒收集器归类为I类(一般控制)。FDA还豁免了这些器械的上市前通知要求。此行动是根据经1976年《医疗器械修正案》(修正案)、1990年《安全医疗器械法案》(SMDA)和1997年《食品药品管理局现代化法案》(FDAMA)修订的《联邦食品、药品和化妆品法案》(该法案)采取的。